GM to increase electric vehicle investment to $35B through 2025
The company said it also will accelerate Ultium battery production in the US.
17 June 2021, 02:44• 3 min readatch up on the developing stories making headlines.General Motors has announced it will increase its investment into electric and autonomous vehicles to $35 billion through 2025.
"We are investing aggressively in a comprehensive and highly-integrated plan to make sure that GM leads in all aspects of the transformation to a more sustainable future," Mary Barra, GM chair and CEO, said in a press release.
Before the pandemic, GM announced an initial $20 billion investment in electric and autonomous vehicles.
GM said the investment will accelerate the company’s Ultium battery production in the United States, with plans to build two new manufacturing plants for the electric batteries by mid-decade.
Anthony Lanzilote/Bloomberg via Getty Images, FILENew vehicles sit in a lot in front of the idled General Motors Co. Flint Assembly plant in F..."There is a strong and growing conviction among our employees, customers, dealers, suppliers, unions and investors, as well as policymakers, that electric vehicles and self-driving technology are the keys to a cleaner, safer world for all," Barra said.
The money will also go toward expanding the rollout of electric vehicles for customers. GM said last year it would deliver 30 new electric cars to the market by 2025.
"GM is targeting annual global EV sales of more than 1 million by 2025, and we are increasing our investment to scale faster because we see momentum building in the United States for electrification, along with customer demand for our product portfolio," Barra said.
ABC News' Sam Sweeney contributed to this report.
- Forums
- ASX - By Stock
- PLS
- Good News & Bad News
Good News & Bad News, page-1447
-
-
- There are more pages in this discussion • 42,943 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.07 |
Change
0.005(0.16%) |
Mkt cap ! $9.210B |
Open | High | Low | Value | Volume |
$3.08 | $3.11 | $3.03 | $37.88M | 12.31M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 71406 | $3.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.07 | 220130 | 55 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 72816 | 3.060 |
51 | 393673 | 3.050 |
32 | 599181 | 3.040 |
50 | 443462 | 3.030 |
39 | 424108 | 3.020 |
Price($) | Vol. | No. |
---|---|---|
3.070 | 224956 | 57 |
3.080 | 551107 | 28 |
3.090 | 379459 | 24 |
3.100 | 473757 | 22 |
3.110 | 559036 | 40 |
Last trade - 14.08pm 15/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online